circumvent these limitations in the field of neurological disorders. They include optogenetics, which has been used to control epilepsy [5, 6, 7] and psychiatric disorders [8, 9] , and designer receptors, which are exclusively active by designer drugs. [10, 11, 12] These techniques allow ondemand interventions, where and when they are needed. However, both approaches require the viral or non-viral transfection of xenomolecules [53, 54] , which still limits their translation to the clinic. [13] In the immediate future, drugs still remain the best mode of action; therefore, progress must be made to by-pass all the above-mentioned problems. An ideal solution would be to deliver drugs directly where they are needed, on demand. In this Communication we use an Organic Electronic Ion Pump (OEIP) to deliver an active substance to tissue slices and control epileptiform activity. We use three different models to induce epileptiform activity and show that delivery of gamma-aminobutyric acid (GABA) results in quick and localized suppression of this activity. As the integration of OEIPs on implantable probes is rather straightforward, we believe that these devices have great potential in drug delivery in the brain, and in particular in delivery of anti-epileptic active substances.
We used epilepsy as a model system to test the device. Epilepsy affects 1 % of the world population and remains drug-resistant in 30 % of the cases. [18, 19] Epilepsy is a prototypical example for which drugs have failed in the clinic because of their toxicity, side effects, or failure to cross the blood brain barrier, despite having strong antiepileptic effects. [20, 21] Controlling drug-resistant epilepsy may still be achieved with these compounds if they could be delivered locally. As a first step in this direction, we used hippocampal slices in which several pharmacological manipulations can be used to evoke epileptiform activity. Lowering the extracellular concentration of Mg 2+ or blocking K + channels with 4-aminopyridine (4AP)
in the perfusion medium produces epileptiform activity that is resistant to common antiepileptic drugs. [22, 23] In order to test the efficacy of the OEIP, we chose to deliver GABA, an endogenous neurotransmitter, which can have an inhibitory effect via its action on GABA A and GABA B receptors. In adult neurons, the activation of GABA A receptors leads to Cl -influx into the cell, hyperpolarizing the cell membrane. In addition, the opening of these channels decreases the membrane resistance, creating a shunt effect, and limiting the effectiveness of excitatory inputs. The net effect is to decrease the firing probability of the cell. The advantages of using GABA are that it is endogenous and that it is quickly taken up and metabolized. [24, 25] It is also particularly relevant in the context of epilepsy since many antiepileptic drugs have been designed to boost GABAergic neurotransmission. [26, 27] OEIPs can be used to deliver ions and small charged molecules, such as neurotransmitters, with high spatial resolution, to stimulate cell activity locally. [50, 51] The OEIP key component is a cation exchange membrane (CEM), a polyanion, which, because of its high concentration of fixed negative charges, is selectively permeable to cations. This inclusion of cations and exclusion of anions is valid as long as the ionic concentrations of the electrolytes in contact with the CEM are low compared to the concentration of fixed charges in the CEM. To "pump"
ions from one electrolyte, through the CEM to the other electrolyte, a voltage is applied across the CEM, and cations in the positively addressed electrolyte are electrophoretically transported through the polyanion. Since anions are excluded from the CEM, the majority of the current through the CEM is due to cation drift (typically for a fixed charge concentration of 1 M in a CEM and 0.1 M electrolytes, 99 % of the mobile ions in the CEM are cations and 1 % are anions). This means that the number of cations that are released at the target electrolyte can be calculated from the current, with 1 µA translating to a delivery rate of 10 nM/second. To run an ionic current through the CEM, two electrodes that can convert an electronic current into an ionic current are needed. We use poly (3,4-ethylenedioxythiophene) doped with polystyrene sulfonate (PEDOT:PSS) electrodes, labeled source electrode and target electrode (Figure 1) . Figure 1 . OEIP delivery of K + directly to neural tissue to induce hyperexcitability a) Due to an applied bias voltage, V pump , cations are electrophoretically transported from the reservoir towards the target, through a CEM made of PSSA-co-MA, and released at the outlets below the tissue. For each ion being delivered, an electron is transferred from the source electrode to the target electrode, oxidizing the source and reducing the target. b) The outlets of the pump are located below the pyramidal cell layer of CA1 area of the mouse hippocampus. A tungsten recording electrode is inserted in the pyramidal cell layer over the outlet of interest to record the field potential and unitary spikes. c) The electrode recorded spontaneous firing. Action potentials were sorted from the complete recording to obtain the change in mean firing rate, determining the approximate number of spikes per second (sps). d) The pump was turned on at the beginning of the displayed recording, as indicated. After approximately 1 minute a significant increase in mean firing rate from 12 sps to over 40 sps was measured (blue trace).
The source electrode is positively biased, which means that holes are injected into the PEDOT of this electrode. To remain charge neutral, cations leave the PEDOT:PSS source electrode as the charge of the PEDOT increases due to the injection of holes. The target electrode is negatively biased, which means that holes are extracted from the PEDOT of this electrode. To remain charge neutral, cations move into the PEDOT:PSS target electrode as the charge of the PEDOT decreases due to the extraction of holes.
The reaction at the positive source electrode can be described by:
where M + is an arbitrary monovalent cation in the electrolyte, x, m and n are integers, and e -is an electron. At the negative target electrode the reverse reaction takes place:
where y and p are integers. The lifetime of the device is limited by the capacity of the PEDOT in electrodes. The device can keep transporting ions, with the above mentioned electrode reactions, as long as there is PEDOT in the source and target to be oxidized and reduced,
respectively. An estimate of device lifetime can be found in the Supplementary section. The OEIP used in this work (Fig. 1a ) has a reservoir electrolyte that contains the cations to be transported (K + or GABA + , 40 mM(aq)) to the chamber containing the neural tissue. The CEM is made from the polyanion poly(styrene sulfonate-co-maleic acid) (PSSA-co-MA) cross-linked with poly(ethylene glycol) (PEG) and is patterned into a large channel that then splits into an array of 32 separate outlets, each 20 µm wide. The pyramidal cell layer of the CA1 area of the mouse hippocampus was placed directly above the outlets of the OEIP. A tungsten recording electrode was then inserted into the pyramidal cell layer directly above one outlet to record close to the outlet. A voltage was sourced to induce a cationic current through the OEIP, and recorded the activity resulting from the cation delivery.
In order to demonstrate the ability of the pump to deliver ions and modify neuronal function, we first used local K + delivery, a procedure known to induce hyperexcitability in mouse hippocampal slices. [29, 30] The outlet of the pump was placed in direct contact with the stratum pyramidale (SP) of the hippocampal CA1 area (Fig. 1b) . A tungsten recording electrode was inserted in SP, directly above the outlet of the pump, to provide immediate electrophysiological recordings of pyramidal cell firing ( concentration is an overestimate since it does not take into account the uptake mechanisms of K + by glial cells. [31] To verify that the increase in activity was not due to the powering of the electronic device itself, we switched on the pump with no cation in the reservoir only DI
water. This did not increase or decrease neuronal activity (not shown). For comparison, direct addition of potassium chloride (3.5 mM) to the perfusion medium (with the ion pump turned off), resulted in similarly increased neuronal activity (compare Fig. 1d and Fig. 2c) . We conclude that neuronal activity can be manipulated on-demand by the local delivery of cations with the OEIP.
To demonstrate the ability of the devices to control epileptiform activity, we used three different models: high K + , [29] low Mg 2+ , [32] and 4AP. [33] GABA has an acidity ( OEIP delivery of GABA to suppress hyperexcitability. Hyperexcitability was induced by adding 3 mM KCl to the perfusion. a) Only positive GABA ions can be delivered through the CEM with its matrix of fixed negative charges. b) Numerical simulations of GABA concentration as it evolves vs distance from one outlet carrying an ionic current 52 of 30 nA are consistent with the analytical estimations made in the Supplementary section. 400 μm at 30 seconds is highlighted, the maximum distance of the recording electrode from the outlet, giving a concentration of approximately 6 μmol/L of GABA. This concentration is enough to begin suppressing activity. c) Spikes were sorted from the complete recording to obtain the change in mean firing rate. The pump was turned on at the beginning of the displayed recording, as indicated. After approximately 1 minute, corresponding to a concentration of 26 μmol/L of GABA from simulations, a significant decrease in mean firing rate (blue trace) was observed.
To demonstrate the delivery and effect of these GABA ions, hyperactivity was first induced by the addition of extra potassium chloride to the perfusion (Figure 2) , elevating the external concentration of K + from 3.5 mM to 7 mM. The tungsten recording electrode was again located in CA1, above the ion pump outlet. The OEIP was then turned on. After approximately 60 s of pumping, CA1 pyramidal cell hyperactivity was suppressed (Fig. 2c) .
The delivery of GABA had no noticeable negative effects on the pyramidal cells, as activity returned to its original levels when the pump was turned-off ( Supplementary Fig. 1 ).
We obtained similar results in the low Mg 2+ model. As seen in Figure 3 (top panels), the ion pump was again placed under CA1 SP with a corresponding tungsten recording electrode. For additional comparison, a second tungsten electrode was located in the SP of the CA3 area.
Epileptiform discharges were abolished within one minute of pumping in the CA1 area, while remaining unaffected in the CA3 region. This demonstrates that the ion pump can control the activity of a given region without interfering with the activity of the nearby region. We chose to control the CA1 region, because the axons from the pyramidal neurons of CA1 do not extend back to CA3. This means that modification in the firing rate of neurons in CA1 cannot directly affect the firing of CA3 pyramidal cells. Finally, delivering GABA also abolished epileptiform activity induced by 4AP (Fig. 3, bottom panels) .
In these experiments, the delivery of GABA was estimated to be 1.75 picomol/second/outlet, corresponding to a local change of 4.5 µM extracellularly in CA1 (calculation details in the Supplementary section). This concentration change is in the same order of magnitude of known quantities of extracellular GABA able to inhibit spontaneous activity, typically between 7 and 20 µM. [34] Once completely diluted in the 500 ml perfusion, this delivered GABA is at a concentration of 3.36 nM, essentially insignificant. Hence, the effect of GABA is due to its direct diffusion into the neuronal tissue, and not by its dilution into ACSF, a conclusion supported by the lack of effect on CA3 pyramidal cell activity. Figure 3 . Suppression of epileptiform activity in the hippocampus with OEIPs. Targeted delivery of GABA from an ion pump located in the CA1 of a mouse hippocampal slice locally inhibits epileptiform activity induced in low Mg 2+ ACSF (top panels) or in the presence of 4AP (bottom panels). The middle traces shows examples of individual epileptiform discharges (field potential) recorded in both conditions. Note that epileptiform discharges stopped in CA1 (right panels) where the pump outlets were located 1 min after turning on the pump, but not in CA3 (left panels), which was not exposed to GABA. A small artifact was seen in CA1, the location of the pump, when the pump was turned on, no artifact was seen in CA3.
We have shown that an OEIP can abolish abnormal electrophysiological activity by ondemand, local delivery of the inhibitory neurotransmitter GABA. Although the mechanisms underlying hyperexcitability induced by high-levels of K + , low Mg 2+ , and 4AP are different, GABA delivery successfully blocked the pathological activity. This means that, despite the fact that there are multiple ways to generate hyperexcitability, [35] local delivery of GABA may work as a general way to control epileptiform activity. This is consistent with the fact that seizures are prevented by GABA boosters in many patients. [36] Studies of such epileptiform propagation in vitro clearly show that, before the epileptiform wavefront, there are very large amplitude inhibitory currents. [38] The progressive loss of these inhibitory currents to pyramidal cells coincides with the progressive increase in the propagation of epileptiform activity. Since this loss of inhibitory control occurs when GABAergic neurons enter into a depolarization block after the onset of epileptiform discharges [35] , the local delivery of GABA could supplement the deficit of GABAergic neuronal activity and restore inhibitory restraint.
Whether the same effect can be obtained in vivo in chronic models of epilepsy remains to be determined. Transferring OEIP technology to the clinic is justified in drug resistant patients with partial onset epilepsy if neurosurgery cannot be performed (for example if it would remove/damage the eloquent cortex). The pumps could be incorporated into the electrodes routinely used in the clinic for long-term deep brain stimulations. The materials and fabrication scheme employed for the in vitro experiments used here for validation are compatible with similar approaches we have used to develop mechanically flexible organic bioelectronic devices for in vivo measurements. [47, 48] Namely, the ion pump can be fabricated on a parylene-C support that would impart a low profile, conformability, implantability and durability, [49] and which can also incorporate electrophysiology and selective biomolecule/ion sensors. Moreover, in contrast to microfluidic delivery devices, OEIPs deliver molecules without any fluid flow and thus with negligible increase in local pressure, which is a requirement in the brain.
In conclusion, we fabricated organic electronic ion pumps using the conducting polymer PEDOT:PSS and a polyanionic copolymer. We used these devices to deliver GABA to tissue slices and demonstrated that epileptiform activity, induced using three different models, can be successfully controlled. These results show that organic electronic ion pumps represent a technological breakthrough for local and timed delivery of active molecules that cannot be delivered in a systemic way.
Experimental Section
Electrophysiological recordings in vitro. 10 mM glucose). Slices were maintained in the chamber at room temperature and allowed to recover for one hour prior to experimental use. After this period of recovery, slices were transferred with a pipette to the surface of the ion pump. The chamber containing the ion pump and slice was continuously perfused with oxygenated ACSF warmed at 33°C. Tungsten electrodes (with a tip resistance of 1-3 MΩ) were positioned in both the CA1 and CA3 region of the hippocampus. Recordings were made with a World Precision Instruments DAM80 AC amplifier, and acquired using an analog-to-digital converter (Digidata 1322B, Molecular Devices). Analysis was performed using using Clampfit (Molecular Devices) or Matlab (Mathworks)-based software.
Ion pump fabrication and characterization.
OEIPs were patterned on a glass wafer, which was first cleaned and oxygen plasma treated removal of S1818 and PMMA in acetone. Parylene-C was subsequently deposited using an SCS Labcoater 2 to a thickness of 2 µm with the use of an adhesion promoting silane. Soap (solution of 1 % in water) was spun and followed by a subsequent parylene-C deposition (2 µm). Finally, the source/target PEDOT:PSS was patterned with the insulating parylene-C using photolithography and a sacrificial peel-off step. A thick layer of AZ9260 (MicroChemicals) photoresist was cast, baked and exposed using a SUSS MJB4 contact aligner, followed by reactive ion etching in an O 2 plasma (160 W, 50 sccm O 2 , 15 min) using an Oxford 80 plus plasma etcher. For the preparation of the PEDOT:PSS films, a 20 ml of aqueous dispersion was made from PEDOT:PSS (PH 1000 from H.C. Stark), 1 ml of ethylene glycol, 50 μl of dodecyl benzene sulfonic acid and 1 wt% of GOPS, and the resulting dispersion was spin-coated at 650 rpm, soft baked at 100°C for 60 s, and spun cast at 650 rpm to attain thicker PEDOT:PSS films. The film is patterned by peel-off of the top parylene C film and subsequently baked at 140 °C for 1 h and were immersed in deionized water to remove any excess low molecular weight compounds. The reservoir chambers, cut from cured polydimethylsiloxane, were affixed to the source (reservoir) and target (bath) areas. During pump operation, voltage (V pump =20 V) was sourced and current measured using a Keithley
